Researchers: Cost of diabetes care on rise
Bloomberg News/Boston Globe, October 29, 2008
Diabetes drug costs in the United States have almost doubled in six years to $12.5 billion as more people are diagnosed and patients receive newer, more expensive treatments, a study has found. Researchers questioned whether these newer drugs are more effective than older, cheaper treatments. About 18 million people in the United States were diagnosed with diabetes in 2007, an increase from 8.1 million in 1994, according to the Centers for Disease Control and Prevention. Worldwide sales of diabetes drugs may jump to $22 billion by 2016, analysts say.
Most Viewed
Most Emailed
- $6.4B Henry Ford, Beaumont Merger Failed on Cultural Hurdles
- House Lawmakers Grill CMS Over Health Exchange Navigators
- Fortunately, Angelina Jolie Isn't On Medicare
- Don't Let Nurses Sink Your Bottom Line
- How Chargemaster Data May Affect Hospital Revenue
- Uncompensated Care Faces a Double Hit in Some States
- Hospital Pricing Transparency a Marketing Game Changer
- ED Physicians Key to Half of Hospital Admissions
- Primary Care Docs Average More Hospital Revenue Than Specialists
- Insurer's App Aims to Lower Healthcare Costs, Securely
